MicroRNA-138 Abates Fibroblast Motility With Effect on Invasion of Adjacent Cancer Cells

Saroj Rajthala1,2, Himalaya Parajuli1,2, Harsh Nitin Dongre1,2

  • 1The Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Frontiers in Oncology
|April 4, 2022
PubMed
Summary

MicroRNA-138 (miR-138) exhibits tumor-suppressive functions in oral squamous cell carcinoma (OSCC)-associated fibroblasts (CAFs). Modulating miR-138 impacts CAF phenotype and OSCC cell invasion, highlighting its therapeutic potential.